COM:IOLCP
IOL Chemicals and Pharmaceuticals Limited
- Stock
Last Close
507.70
25/09 10:00
Market Cap
24.69B
Beta: -
Volume Today
417.58K
Avg: -
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Mar '14 | Mar '15 | Mar '16 | Mar '17 | Mar '18 | Mar '19 | Mar '20 | Mar '21 | Mar '22 | Mar '23 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
average inventory | 1.78B - | 2.03B 14.04% | 2.21B 8.81% | 2.45B 11.15% | 2.35B 4.18% | 1.98B 15.69% | 1.88B 5.03% | 2.41B 28.24% | 3.53B 46.07% | 3.68B 4.31% | |
average payables | 1.04B - | 918.11M 12.04% | 934.36M 1.77% | 1.35B 44.72% | 1.43B 5.91% | 1.26B 11.71% | 1.53B 21.15% | 2.12B 38.70% | 3.24B 52.53% | 3.62B 11.63% | |
average receivables | 938.05M - | 938.05M 0% | 1.82B - | 4.40B 142.11% | 5.12B 16.37% | ||||||
book value per share | 76.86 - | 51.98 32.38% | 35.15 32.38% | 33.69 4.14% | 38.38 13.93% | 84.39 119.85% | 143.01 69.46% | 216.08 51.10% | 237.20 9.77% | 256.81 8.27% | |
capex per share | -5.02 - | -1.48 70.45% | -5.06 241.61% | -3.99 21.22% | -8.60 115.71% | -10.77 25.16% | -14.11 31.05% | -18.55 31.46% | -26.11 40.75% | -36.08 38.17% | |
capex to depreciation | -0.43 - | -0.20 52.66% | -0.90 339.59% | -0.75 16.67% | -1.60 113.83% | -1.87 17.10% | -2.25 19.86% | -2.78 23.74% | -3.54 27.45% | -4.59 29.50% | |
capex to operating cash flow | -0.17 - | 0.13 171.91% | -1.51 1,297.59% | -0.29 80.90% | -0.40 40.33% | -0.22 45.14% | -0.17 23.09% | -0.28 67.20% | -1.65 478.18% | -1.73 5.16% | |
capex to revenue | -0.02 - | -0.02 36.63% | -0.05 199.20% | -0.03 31.35% | -0.05 59.32% | -0.04 27.24% | -0.04 17.79% | -0.06 29.07% | -0.07 27.14% | -0.10 35.14% | |
cash per share | 4.20 - | 3.19 24.17% | 2.27 28.66% | 2.93 28.58% | 0.14 95.13% | 2.40 1,583.64% | 22.99 859.54% | 57.71 150.97% | 20.45 64.56% | 7.97 61.05% | |
days of inventory on hand | 189.67 - | 278.98 47.09% | 201.16 27.90% | 195.29 2.92% | 106.42 45.51% | 64.61 39.29% | 63.10 2.33% | 95.83 51.86% | 93.70 2.22% | 76.80 18.04% | |
days payables outstanding | 111.87 - | 91.83 17.91% | 102.92 12.08% | 114.38 11.14% | 68.02 40.53% | 41.14 39.51% | 62.62 52.20% | 77.54 23.83% | 93.56 20.66% | 74.13 20.77% | |
days sales outstanding | 71.17 - | 68.10 - | 86.86 27.54% | 83.47 3.90% | |||||||
debt to assets | 0.42 - | 0.57 34.17% | 0.58 3.08% | 0.55 6.35% | 0.51 6.13% | 0.30 41.27% | 0.05 83.22% | 0.00 96.65% | 0.02 1,220.93% | 0.04 76.22% | |
debt to equity | 1.50 - | 1.92 28.28% | 2.45 27.58% | 2.36 3.46% | 1.96 17.25% | 0.60 69.38% | 0.07 87.79% | 0.00 97.04% | 0.03 1,357.22% | 0.05 67.71% | |
dividend yield | 0.02 - | 0.01 64.45% | 0.02 132.12% | 0.01 16.57% | |||||||
earnings yield | 0.06 - | -0.58 1,088.85% | -0.10 82.99% | 0.01 112.01% | 0.06 410.17% | 0.21 245.15% | 0.36 71.61% | 0.14 61.68% | 0.08 41.64% | 0.08 3.76% | |
enterprise value | 3.57B - | 4.99B 39.61% | 8.44B 69.12% | 7.85B 6.97% | 8.76B 11.55% | 13.96B 59.40% | 10.32B 26.05% | 31.84B 208.47% | 21.17B 33.51% | 17.39B 17.85% | |
enterprise value over ebitda | 3.73 - | 66.12 1,671.47% | 23.03 65.17% | 9.12 60.39% | 7.23 20.70% | 3.36 53.53% | 1.76 47.51% | 5.21 195.17% | 7.41 42.36% | 6.92 6.65% | |
ev to operating cash flow | 4.58 - | -10.62 332.03% | 47.66 548.69% | 10.08 78.86% | 7.31 27.42% | 5.11 30.14% | 2.19 57.12% | 8.38 282.63% | 22.75 171.39% | 14.22 37.48% | |
ev to sales | 0.63 - | 1.30 104.48% | 1.45 12.10% | 1.10 24.02% | 0.91 17.60% | 0.84 7.34% | 0.55 34.32% | 1.64 195.37% | 0.98 40.32% | 0.78 19.65% | |
free cash flow per share | 23.65 - | -13.26 156.07% | -1.70 87.16% | 9.87 679.42% | 12.70 28.65% | 37.83 197.96% | 68.70 81.60% | 46.56 32.23% | -10.26 122.04% | -15.25 48.65% | |
free cash flow yield | 1.15 - | -0.46 140.19% | -0.02 95.19% | 0.16 803.22% | 0.16 0.17% | 0.19 20.36% | 0.39 106.63% | 0.08 78.36% | -0.03 134.33% | -0.05 85.88% | |
graham net net | -155.85 - | -94.07 39.64% | -88.24 6.20% | -85.58 3.02% | -64.18 25.01% | -63.98 0.30% | -24.16 62.24% | 69.75 388.68% | 24.22 65.28% | 12.84 46.98% | |
graham number | 45.78 - | 139.83 205.44% | 77.52 44.56% | 23.88 69.20% | 65.24 173.23% | 282.77 333.42% | 452.06 59.87% | 608.72 34.66% | 390.42 35.86% | 370.06 5.22% | |
income quality | 23.66 - | 0.70 97.02% | -0.46 165.17% | 14.22 3,197.05% | 3.82 73.10% | 0.81 78.75% | 0.88 8.71% | 0.66 24.77% | 0.41 37.74% | 0.65 56.62% | |
intangibles to total assets | 0.00 - | 0.00 22.84% | 0.00 200.03% | 0.00 9.02% | 0.00 6.35% | 0.00 35.44% | 0.00 44.78% | 0.00 12.67% | 0.00 377.51% | 0.00 143.01% | |
interest coverage | -1.39 - | -0.85 39.16% | 0.11 112.82% | 1.54 1,315.96% | 8.21 433.15% | 34.31 317.89% | 608.96 1,675.01% | 99.70 83.63% | 12.45 87.51% | ||
interest debt per share | 114.96 - | 113.29 1.45% | 94.65 16.45% | 88.57 6.43% | 85.56 3.40% | 58.82 31.25% | 13.27 77.44% | 0.63 95.26% | 7.90 1,155.69% | 16.40 107.58% | |
inventory turnover | 1.92 - | 1.31 32.01% | 1.81 38.69% | 1.87 3.00% | 3.43 83.51% | 5.65 64.71% | 5.78 2.39% | 3.81 34.15% | 3.90 2.27% | 4.75 22.01% | |
invested capital | 1.50 - | 1.92 28.28% | 2.45 27.58% | 2.36 3.46% | 1.96 17.25% | 0.60 69.38% | 0.07 87.79% | 0.00 97.04% | 0.03 1,357.22% | 0.05 67.71% | |
market cap | 558.09M - | 1.14B 104.28% | 4.02B 252.98% | 3.54B 12.08% | 4.54B 28.44% | 11.25B 147.57% | 10.01B 11.06% | 32.13B 221.10% | 20.76B 35.38% | 16.61B 20.03% | |
net current asset value | -2.51B - | -2.11B 16.01% | -2.31B 9.28% | -2.16B 6.22% | -2.10B 2.95% | 205.20M 109.78% | 3.09B 1,405.46% | 6.73B 117.74% | 5.11B 24.03% | 4.06B 20.55% | |
net debt to ebitda | 3.15 - | 51.01 1,519.56% | 12.04 76.39% | 5.01 58.41% | 3.48 30.55% | 0.65 81.27% | 0.05 91.76% | -0.05 190.23% | 0.14 392.05% | 0.31 120.63% | |
net income per share | 1.21 - | -16.72 1,479.57% | -7.60 54.55% | 0.75 109.90% | 4.93 555.23% | 42.11 754.46% | 63.51 50.82% | 76.21 20.00% | 28.56 62.52% | 23.70 17.02% | |
operating cash flow per share | 28.67 - | -11.78 141.09% | 3.36 128.52% | 13.86 312.40% | 21.30 53.71% | 48.60 128.16% | 82.81 70.40% | 65.11 21.38% | 15.85 75.66% | 20.83 31.39% | |
payables turnover | 3.26 - | 3.97 21.82% | 3.55 10.78% | 3.19 10.02% | 5.37 68.15% | 8.87 65.33% | 5.83 34.30% | 4.71 19.24% | 3.90 17.12% | 4.92 26.21% | |
receivables turnover | 5.13 - | 5.36 - | 4.20 21.59% | 4.37 4.05% | |||||||
research and ddevelopement to revenue | |||||||||||
return on tangible assets | 0.00 - | -0.10 2,233.96% | -0.05 45.65% | 0.01 110.02% | 0.03 552.42% | 0.25 645.14% | 0.31 22.25% | 0.28 10.17% | 0.09 69.01% | 0.07 19.26% | |
revenue per share | 206.99 - | 96.51 53.37% | 110.19 14.17% | 126.44 14.75% | 171.18 35.39% | 294.44 72.00% | 327.58 11.25% | 333.64 1.85% | 369.36 10.71% | 377.64 2.24% | |
roe | 0.02 - | -0.32 2,140.06% | -0.22 32.79% | 0.02 110.33% | 0.13 475.10% | 0.50 288.65% | 0.44 11.00% | 0.35 20.58% | 0.12 65.86% | 0.09 23.36% | |
roic | 0.01 - | -0.11 1,844.42% | -0.06 43.10% | 0.01 110.59% | 0.13 1,799.43% | 0.36 182.02% | 0.42 19.39% | 0.35 17.13% | 0.13 64.28% | 0.10 24.18% | |
sales general and administrative to revenue | 0.00 - | 0.00 6.62% | 0.00 19.85% | 0.00 15.96% | 0.00 48.43% | 0.00 58.94% | 0.00 0.28% | 0.00 26.71% | |||
shareholders equity per share | 76.86 - | 51.98 32.38% | 35.15 32.38% | 33.69 4.14% | 38.38 13.93% | 84.39 119.85% | 143.01 69.46% | 216.08 51.10% | 237.20 9.77% | 256.81 8.27% | |
stock based compensation to revenue | |||||||||||
tangible asset value | 2.09B - | 2.07B 1.00% | 1.84B 11.00% | 1.88B 2.32% | 2.15B 13.97% | 4.74B 120.55% | 8.13B 71.67% | 12.60B 54.95% | 13.89B 10.25% | 14.99B 7.91% | |
tangible book value per share | 76.86 - | 51.98 32.38% | 35.15 32.38% | 33.69 4.14% | 38.21 13.40% | 84.26 120.53% | 142.92 69.62% | 215.98 51.12% | 236.59 9.54% | 255.30 7.91% | |
working capital | 113.33M - | 749.47M 561.31% | 763.76M 1.91% | 859.64M 12.55% | 819.90M 4.62% | 2.31B 181.95% | 3.89B 68.12% | 7.32B 88.28% | 5.67B 22.46% | 4.64B 18.20% |
All numbers in (except ratios and percentages)